α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen–Expressing Human Colon Cancer Xenografts

Sandra Heskamp; Reinier Hernandez; Janneke D.M. Molkenboer-Kuenen; Markus Essler; Frank Bruchertseifer; Alfred Morgenstern; Erik J. Steenbergen; Weibo Cai; Christof Seidl; William J. McBride; David M. Goldenberg; Otto C. Boerman

doi:10.2967/jnumed.116.187021

Research ArticleTheranostics

α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen–Expressing Human Colon Cancer Xenografts

Sandra Heskamp, Reinier Hernandez, Janneke D.M. Molkenboer-Kuenen, Markus Essler, Frank Bruchertseifer, Alfred Morgenstern, Erik J. Steenbergen, Weibo Cai, Christof Seidl, William J. McBride, David M. Goldenberg and Otto C. Boerman

Journal of Nuclear Medicine June 2017, 58 (6) 926-933; DOI: https://doi.org/10.2967/jnumed.116.187021

Sandra Heskamp

1Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Reinier Hernandez

2Medical Physics Department, University of Wisconsin–Madison, Madison, Wisconsin

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Janneke D.M. Molkenboer-Kuenen

1Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Markus Essler

3Klinik und Poliklinik fur Nuklearmedizin, University of Bonn, Bonn, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Frank Bruchertseifer

4European Commission, Joint Research Centre–Directorate for Nuclear Safety and Security, Karlsruhe, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Alfred Morgenstern

4European Commission, Joint Research Centre–Directorate for Nuclear Safety and Security, Karlsruhe, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Erik J. Steenbergen

5Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Weibo Cai

2Medical Physics Department, University of Wisconsin–Madison, Madison, Wisconsin

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Christof Seidl

6Department of Nuclear Medicine, Technische Universität München, Munich, Germany

7Department of Obstetrics and Gynecology, Technische Universität München, Munich, Germany; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

William J. McBride

8Immunomedics, Inc., Morris Plains, New Jersey

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

David M. Goldenberg

8Immunomedics, Inc., Morris Plains, New Jersey

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Otto C. Boerman

1Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 58, Issue 6

June 1, 2017

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen–Expressing Human Colon Cancer Xenografts

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen–Expressing Human Colon Cancer Xenografts

Journal of Nuclear Medicine Jun 2017, 58 (6) 926-933; DOI: 10.2967/jnumed.116.187021

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen–Expressing Human Colon Cancer Xenografts

Journal of Nuclear Medicine Jun 2017, 58 (6) 926-933; DOI: 10.2967/jnumed.116.187021

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

Theranostic GPA33-Pretargeted Radioimmunotherapy of Human Colorectal Carcinoma with a Bivalent 177Lu-Labeled Radiohapten
Efficacy of HER2-Targeted Intraperitoneal 225Ac {alpha}-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal Carcinomatosis
Profound immunomodulatory effects of 225Ac-NM600 drive enhanced anti-tumor response in prostate cancer
Pretargeting: A Path Forward for Radioimmunotherapy
Mathematical Modeling of Preclinical Alpha-Emitter Radiopharmaceutical Therapy

Google Scholar

Theranostics

Can ¹⁷⁷Lu-DOTATATE Kidney Absorbed Doses be Predicted from Pretherapy SSTR PET? Findings from Multicenter Data
Determination of the Intralesional Distribution of Theranostic ¹²⁴I-Omburtamab Convection-Enhanced Delivery in Treatment of Diffuse Intrinsic Pontine Glioma
Evidence-Based Clinical Protocols to Monitor Efficacy of [¹⁷⁷Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data

Show more Theranostics

Basic

Dopamine D₁ Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
Synthesis and Preclinical Evaluation of a ⁶⁸Ga-Labeled Adnectin, ⁶⁸Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression

Show more Basic

Keywords

radiochemistry
radionuclide therapy
Bi-213
CEA
pretargeting
targeted alpha therapy

Main menu

User menu

Search

α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen–Expressing Human Colon Cancer Xenografts

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Theranostics

Basic

Similar Articles

Keywords